Mastek Q1 FY'26: Revenue ₹915 Cr, Up 12.5% YoY; Net Profit ₹92.1 Cr, Up 28.7% YoY
The announcement details significant financial performance metrics, new strategic initiatives in AI, and major deal wins, suggesting a high impact on the company's future prospects.
Strong revenue and profit growth, especially in the UK market, and positive outlook regarding AI and new deals indicate a positive sentiment.
* Mastek Limited announced its Q1 FY'26 results with total revenue of ₹915 crore, a 12.5% year-on-year growth, and net profit of ₹92.1 crore, reflecting a 28.7% year-on-year increase. * UK & Europe business drove growth with a 27% year-on-year increase in reported currency. * US market faced headwinds with flat year-on-year revenue, but order books grew by 25% quarter-on-quarter. * AMEA market revenue declined due to a focus on profitable growth. * Operating EBITDA margins stood at 15% for the quarter. * The company secured a 2-year extension-cum-renewal with a major client, involving a significant discount. * Cash and cash equivalents stood at ₹549 crore. * 12-month order backlog stood at $274 million (₹2,290.99 crore), a 3.5% quarter-on-quarter growth. * Mastek is actively involved in AI with more than 10 accounts working on proofs of concept. * The company is in the process of selecting a President for US and a CFO at the corporate level. * The UK government reiterated commitment to increased spending in digital and tech, including a £3.25 billion (₹34,148.43 crore) transformation fund focused on public services, digital transformation, and AI-led initiatives. * NHS received £10 billion (₹1,05,072.10 crore) over the next 5 years for digital, technology, and infrastructure improvement. * Mastek secured a large deal (over $15 million or ₹125.49 crore) with a financial services regulatory organization in the UK, driven by data and transformation of their data landscape.
What to do with a filing like this
Mastek Limited filed this with the NSE as a statutory disclosure, categorised under results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mastek Limited. Read the original for the full detail.